BRCA2 c.156_157insAlu accounted 46% of BRCA PVs in the Portuguese cancer cohort in our current study, much higher than the originally reported one-fourth, 33.6% or 37.9% [68–70]. This evidence concerns the gene BRCA2 and cancer.